Citius Pharmaceuticals Presents At The 2017 Marcum MicroCap Conference

Tuesday, June 13, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 13, 2017 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (OTC BB: CTXR), a specialty pharmaceutical

company focused on adjunctive cancer care and critical care drug products, is presenting to investors at the 2017 Marcum MicroCap Conference on June 15. The Marcum conference is a highlight on the annual investment community
calendar in New York City.

Citius is scheduled to present at 2:30 PM. Leonard Mazur, the Executive Chairman of Citius, along with Myron Holubiak, President and Chief Executive Officer, will jointly deliver the corporate presentation and provide an overview of the company including recent business developments. To arrange a meeting with management, please contact Mr. Andrew Scott: ascott@citiuspharma.com.

Citius is currently advancing two product candidates: Mino-Lok™ which is entering Phase 3 trials, and a Corticosteroid/Lidocaine formulation that is entering Phase 2b. The markets for these products are large and underserved, and provide unique exclusive positions for Citius.

The Marcum MicroCap Conference (www.marcummicrocap.com) is a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. More than 2000 investors and other participants from every segment of the microcap marketplace attend each year, including venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, and buy- and sell-side analysts, as well as senior executive teams from presenting companies and service providers to the microcap marketplace.

The conference is presented by Marcum LLP, a top national accounting and advisory firm registered with the Public Company Accounting Oversight Board (PCAOB). Marcum's Assurance Division provides the most up-to-date service and guidance on SEC accounting and reporting issues. Services include Financial Statement Audits in accordance with PCAOB standards; Tax Compliance and Advisory Services; Due Diligence; Agreed-Upon Procedures and Other Attest Work; Internal Audit Services; Sarbanes-Oxley Section 404 Compliance Services and Software; Technical Accounting Assistance; and IPO Assistance. For more information, visit www.marcumllp.com.

About Citius Pharmaceuticals, Inc. Citius is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infectives, cancer care and unique prescription products using innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients.  We seek to achieve leading market positions by providing therapeutic products that address unmet medical needs.  By using previously approved drugs with substantial safety and efficacy data, we seek to reduce the risks associated with pharmaceutical product development and regulatory requirements. We focus on developing products that have intellectual property protection and competitive advantages to existing therapeutic approaches. www.citiuspharma.com

Contact: Andrew Scott, Vice President, Corporate Development   ascott@citiuspharma.com 646-522-8410

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/citius-pharmaceuticals-presents-at-the-2017-marcum-microcap-conference-300473142.html

SOURCE Citius Pharmaceuticals, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook